Advertisement

Related Videos

Peter Clark, MA, MD, FRCP: A Payer Perspective

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Advertisement

Advertisement




Jun
23
Today In Oncology
GLP-1 Receptor Agonists Linked to Lower Colorectal Cancer Risk in Patients With IBD
Chinese Study of HER2-Targeted Combination Therapy for Locally Advanced Breast Cancer
Multi-Cancer Early Detection Test Performs Well in Real-World Asian Cohort
Early Palliative Care Improves Quality of Life for Patients With Breast Cancer in India
Aumolertinib Plus Chemotherapy in EGFR-Mutated Advanced NSCLC
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo